About Us

Our Mission

IMD Path we are a Molecular Diagnostics Laboratory investing in the technology, information systems and business infrastructure enabling community based Pathology groups in their diagnostic mission and empowering Oncologist in both First Line and Advanced-stage cancer management of their patients.

We presently operate two facilities in Berkeley CA and Aurora CO. These labs represent our template for functional and strategic alignment in support the “local” immediate diagnostic needs of our patients as enabled by our PSI Berkeley CA regional lab, bolstered by IMD’s Academic level Esoteric Center of Excellence in Anschutz Medical Campus at the University of Colorado…IMD’s “hub and spoke” model of care for Oncology.

At IMD “value based care” is not a marketing term but to our founders, investors, collaborators, and dedicated staff’s continuous mission to define, quality care as…achieving positive patient outcomes at reasonable cost!

INTEGRATE
We aim to simplify a complex system through integration of the commercial laboratory business model to independent pathology groups.
INVEST
In order to provide top of the line and consistent results, we invest in Molecular Diagnostics Laboratories supported by an academic level medical expertise.
EMPOWER
Through the empowerment of symbiotic relationships to ultimately improve patients navigation of the Oncology experience in targeted treatment.

Management

Stephen Bauer MD
Stephen Bauer MDChief Executive Officer
Dr. Bauer has extensive experience in Anatomic and Clinical Pathology practice in both community hospitals and independent laboratories. His career has focused on combining solid clinical practices and business platforms for Pathology Practices to thrive and play an integral role in diagnostic medicine. [more]
Louis Tzoumbas
Louis TzoumbasChief Operating Officer
Louis Tzoumbas, has developed a forty plus year career in the Healthcare Industry. Throughout his expansive career he has held multiple director and executive roles with well-recognized organizations such as: Unilab (present-day Quest Diagnostics) and Stanford Medical Centers Clinical Outreach Programs. [more]
Su Chen MD
Su Chen MDChief Medical Officer
Dr. Su Chen serves as Chief Medical Officer (CMO) and Medical Director of PSI a wholly owned subsidiary of IMD Path, with facilities in Berkeley CA. Dr. Chen also is Medical Director of IMD’s Esoteric Molecular Labs in Aurora CO. He holds board certification by the American Board of Pathology in Molecular [more]

Israel Villasenor
Israel VillasenorEVP|Business Development
Israel Villasenor has been a part of the Healthcare and Lab Industry for twenty years. He has played crucial roles in helping facilitate the mergers of major organizations including Unilab to Quest Diagnostics and Stanford Outpatient Clinical Labs to LabCorp of America. Additionally, he has managed regional [more]